Cargando…
Management and prognosis of pancreatic cancer over a 30-year period
BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720200/ https://www.ncbi.nlm.nih.gov/pubmed/19568238 http://dx.doi.org/10.1038/sj.bjc.6605150 |
_version_ | 1782170114740715520 |
---|---|
author | David, M Lepage, C Jouve, J-L Jooste, V Chauvenet, M Faivre, J Bouvier, A-M |
author_facet | David, M Lepage, C Jouve, J-L Jooste, V Chauvenet, M Faivre, J Bouvier, A-M |
author_sort | David, M |
collection | PubMed |
description | BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I–II was 2.8% in the 1976–1980 period and 8.8% in the 2001–2005 period (P<0.001). There was a similar trend in the proportion of cases resected for cure, the corresponding percentages being 4.5 and 11.3%, respectively (P<0.001). The 5-year relative survival increased from 2.0 to 4.2% (P<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology. |
format | Text |
id | pubmed-2720200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27202002010-07-21 Management and prognosis of pancreatic cancer over a 30-year period David, M Lepage, C Jouve, J-L Jooste, V Chauvenet, M Faivre, J Bouvier, A-M Br J Cancer Clinical Study BACKGROUND: The aim of this study was to report on changes in the diagnostic assessment, patterns of care and survival over time for pancreatic cancers. METHODS: A total of 2986 cases of pancreatic cancer from the Digestive Cancer Registry of Burgundy (France) over a 30-year period (1976–2005) were considered. Non-conditional logistic regressions were carried out to identify the factors associated with resection for cure and with the use of chemotherapy. A multivariate relative survival analysis was carried out. RESULTS: Diagnostic procedures have changed. Ultrasonography and computed tomography progressively have become the major diagnostic procedures. There was a slight improvement in stage: the proportion of stage I–II was 2.8% in the 1976–1980 period and 8.8% in the 2001–2005 period (P<0.001). There was a similar trend in the proportion of cases resected for cure, the corresponding percentages being 4.5 and 11.3%, respectively (P<0.001). The 5-year relative survival increased from 2.0 to 4.2% (P<0.001). In the multivariate relative survival analysis, the period remained a significant prognostic factor. Stage, sex, age and histology were independent prognostic factors. CONCLUSION: Over a 30-year period, there were minor changes in the stage at diagnosis, resection for cure and prognosis of pancreatic cancers, although there were improvements in the diagnostic modalities. Pancreatic cancer still represents a major challenge in oncology. Nature Publishing Group 2009-07-21 2009-06-30 /pmc/articles/PMC2720200/ /pubmed/19568238 http://dx.doi.org/10.1038/sj.bjc.6605150 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study David, M Lepage, C Jouve, J-L Jooste, V Chauvenet, M Faivre, J Bouvier, A-M Management and prognosis of pancreatic cancer over a 30-year period |
title | Management and prognosis of pancreatic cancer over a 30-year period |
title_full | Management and prognosis of pancreatic cancer over a 30-year period |
title_fullStr | Management and prognosis of pancreatic cancer over a 30-year period |
title_full_unstemmed | Management and prognosis of pancreatic cancer over a 30-year period |
title_short | Management and prognosis of pancreatic cancer over a 30-year period |
title_sort | management and prognosis of pancreatic cancer over a 30-year period |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720200/ https://www.ncbi.nlm.nih.gov/pubmed/19568238 http://dx.doi.org/10.1038/sj.bjc.6605150 |
work_keys_str_mv | AT davidm managementandprognosisofpancreaticcancerovera30yearperiod AT lepagec managementandprognosisofpancreaticcancerovera30yearperiod AT jouvejl managementandprognosisofpancreaticcancerovera30yearperiod AT joostev managementandprognosisofpancreaticcancerovera30yearperiod AT chauvenetm managementandprognosisofpancreaticcancerovera30yearperiod AT faivrej managementandprognosisofpancreaticcancerovera30yearperiod AT bouvieram managementandprognosisofpancreaticcancerovera30yearperiod |